SOAT1 and hepatocellular carcinoma: Recently, Justin Jit Hin Tang et al. (2020) discussed the JAK/STAT signaling in hepatocellular carcinoma and organized different JAK/STAT inhibitors used in targeting the JAK/STAT pathway for HCC treatment, including small molecule inhibitors and siRNAs [39].